310 related articles for article (PubMed ID: 28846745)
21. Structural MRI substrates of cognitive impairment in neuromyelitis optica.
Liu Y; Fu Y; Schoonheim MM; Zhang N; Fan M; Su L; Shen Y; Yan Y; Yang L; Wang Q; Zhang N; Yu C; Barkhof F; Shi FD
Neurology; 2015 Oct; 85(17):1491-9. PubMed ID: 26423432
[TBL] [Abstract][Full Text] [Related]
22. Gray Matter Volume Reduction Is Associated with Cognitive Impairment in Neuromyelitis Optica.
Wang Q; Zhang N; Qin W; Li Y; Fu Y; Li T; Shao J; Yang L; Shi FD; Yu C
AJNR Am J Neuroradiol; 2015 Oct; 36(10):1822-9. PubMed ID: 26338914
[TBL] [Abstract][Full Text] [Related]
23. Assessment of intelligence quotient in patients with neuromyelitis optica spectrum disease and multiple sclerosis.
Ashtari F; Manouchehri N; Shaygannejad V; Barekatain M; Adibi I; Afshari-Safavi A; Ramezani N; Ghalamkari A; Barzegar M
Mult Scler Relat Disord; 2023 Feb; 70():104492. PubMed ID: 36587484
[TBL] [Abstract][Full Text] [Related]
24. White matter atrophy in brain of neuromyelitis optica: a voxel-based morphometry study.
Duan Y; Liu Y; Liang P; Jia X; Ye J; Dong H; Li K
Acta Radiol; 2014 Jun; 55(5):589-93. PubMed ID: 23966367
[TBL] [Abstract][Full Text] [Related]
25. Multimodal magnetic resonance imaging quantification of gray matter alterations in relapsing-remitting multiple sclerosis and neuromyelitis optica spectrum disorder.
Andica C; Hagiwara A; Yokoyama K; Kato S; Uchida W; Nishimura Y; Fujita S; Kamagata K; Hori M; Tomizawa Y; Hattori N; Aoki S
J Neurosci Res; 2022 Jul; 100(7):1395-1412. PubMed ID: 35316545
[TBL] [Abstract][Full Text] [Related]
26. Comparison of diffusion tensor imaging (DTI) tissue characterization parameters in white matter tracts of patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD).
Chen X; Roberts N; Zheng Q; Peng Y; Han Y; Luo Q; Feng J; Luo T; Li Y
Eur Radiol; 2024 Jan; ():. PubMed ID: 38175221
[TBL] [Abstract][Full Text] [Related]
27. Diffusion tensor imaging of normal-appearing white matter in patients with neuromyelitis optica spectrum disorder and multiple sclerosis.
Kim SH; Kwak K; Hyun JW; Joung A; Lee SH; Choi YH; Lee JM; Kim HJ
Eur J Neurol; 2017 Jul; 24(7):966-973. PubMed ID: 28643955
[TBL] [Abstract][Full Text] [Related]
28. [A voxel-based morphometry study of grey matter volume changes in neuromyelitis optica patients].
Chen C; Hou B; You H; Lv YL; Xu Y; Feng F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Aug; 36(4):432-8. PubMed ID: 25176214
[TBL] [Abstract][Full Text] [Related]
29. A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis.
Outteryck O; Majed B; Defoort-Dhellemmes S; Vermersch P; Zéphir H
Mult Scler; 2015 Dec; 21(14):1781-93. PubMed ID: 25828758
[TBL] [Abstract][Full Text] [Related]
30. Spinal cord and brain atrophy patterns in neuromyelitis optica spectrum disorder and multiple sclerosis.
Hua T; Fan H; Duan Y; Tian D; Chen Z; Xu X; Bai Y; Li Y; Zhang N; Sun J; Li H; Li Y; Li Y; Zeng C; Han X; Zhou F; Huang M; Xu S; Jin Y; Li H; Zhuo Z; Zhang X; Liu Y
J Neurol; 2024 Jun; 271(6):3595-3609. PubMed ID: 38558149
[TBL] [Abstract][Full Text] [Related]
31. Significance of gray matter brain lesions in multiple sclerosis and neuromyelitis optica.
Kawachi I; Nishizawa M
Neuropathology; 2015 Oct; 35(5):481-6. PubMed ID: 26079808
[TBL] [Abstract][Full Text] [Related]
32. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
33. Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis.
Tur C; Penny S; Khaleeli Z; Altmann DR; Cipolotti L; Ron M; Thompson AJ; Ciccarelli O
Mult Scler; 2011 Nov; 17(11):1324-32. PubMed ID: 21803874
[TBL] [Abstract][Full Text] [Related]
34. Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis.
Masuda H; Mori M; Uzawa A; Uchida T; Ohtani R; Kuwabara S
PLoS One; 2020; 15(4):e0224419. PubMed ID: 32251416
[TBL] [Abstract][Full Text] [Related]
35. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
[TBL] [Abstract][Full Text] [Related]
36. Disrupted structural network of inferomedial temporal regions in relapsing-remitting multiple sclerosis compared with neuromyelitis optica spectrum disorder.
Cho EB; Kim D; Jeong B; Shin JH; Chung YH; Kim ST; Kim BJ; Han CE; Min JH
Sci Rep; 2022 Mar; 12(1):5152. PubMed ID: 35338192
[TBL] [Abstract][Full Text] [Related]
37. Multimodal characterization of gray matter alterations in neuromyelitis optica.
Liu Y; Jiang X; Butzkueven H; Duan Y; Huang J; Ren Z; Dong H; Shi FD; Barkhof F; Li K; Wang J
Mult Scler; 2018 Sep; 24(10):1308-1316. PubMed ID: 28741987
[TBL] [Abstract][Full Text] [Related]
38. Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder.
Nakamura Y; Liu Z; Fukumoto S; Shinoda K; Sakoda A; Matsushita T; Hayashida S; Isobe N; Watanabe M; Hiwatashi A; Yamasaki R; Kira JI
Eur J Neurol; 2020 Jan; 27(1):92-99. PubMed ID: 31304648
[TBL] [Abstract][Full Text] [Related]
39. White matter atrophy and cognitive dysfunctions in neuromyelitis optica.
Blanc F; Noblet V; Jung B; Rousseau F; Renard F; Bourre B; Longato N; Cremel N; Di Bitonto L; Kleitz C; Collongues N; Foucher J; Kremer S; Armspach JP; de Seze J
PLoS One; 2012; 7(4):e33878. PubMed ID: 22509264
[TBL] [Abstract][Full Text] [Related]
40. Cognitive impairment and gray/white matter volume abnormalities in pediatric patients with Turner syndrome presenting with various karyotypes.
Zhao Q; Zhang Z; Xie S; Pan H; Zhang J; Gong G; Cui Z
J Pediatr Endocrinol Metab; 2013; 26(11-12):1111-21. PubMed ID: 23846137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
